Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
20
2022
PLCB Approves Sales of CBD Products Norris McLaughlin P.A.
Jan
20
2022
DOT Random Drug and Alcohol Testing Rates for 2022 Jackson Lewis P.C.
Jan
19
2022
At-Home COVID-19 Testing Options and Alternatives Jackson Lewis P.C.
Jan
19
2022
Cargill Announces Planned Acquisition Of Croda’s Biobased Industrial Business Bergeson & Campbell, P.C.
Jan
19
2022
Japan at a Crossroads: Reconciling Drug Price Reform and Innovation Greenberg Traurig, LLP
Jan
19
2022
Video: SCOTUS Decides on Vaccine Rules, Companies Can Still Require Vaccination, Restrictive Covenants in CO – Employment Law This Week Epstein Becker & Green, P.C.
Jan
19
2022
GT Legal Food Talk Episode 13: Regulatory Roundtable – What's on the Menu in 2022? [PODCAST] Greenberg Traurig, LLP
Jan
19
2022
New York Enacts Landmark Legislation Regulating PBMs Proskauer Rose LLP
Jan
19
2022
FDA Publishes Paper on Asbestos Testing in Cosmetics Keller and Heckman LLP
Jan
19
2022
Securities Litigation Update: Federal Courts Allow Section 10(b) Claims Based on Non-Fraudulent “Channel Stuffing” and Hyped COVID-19 Vaccine Candidate Cadwalader, Wickersham & Taft LLP
Jan
19
2022
Coffee Burn Injury Lawsuits Buckfire Law
Jan
18
2022
“Show More of You”: Amgen v. Sandoz, Battling it Out on Amgen’s Otezla® Drug Finnegan
Jan
18
2022
US Federal Labor Viewpoints – Week of January 10, 2022 Squire Patton Boggs (US) LLP
Jan
18
2022
COVID-19 Vaccination Sweepstakes: Best Practices for Employee Incentives K&L Gates
Jan
18
2022
New Guidelines for Good Manufacturing Practices Concerning Medical Devices in Mexico OLIVARES
Jan
18
2022
Federal Marijuana Reform: You Can’t Always Get What You Want? Bradley Arant Boult Cummings LLP
Jan
18
2022
Co-Owner of Clinical Trial Company Pleads Guilty to Obstruction of Justice in Connection with Falsification of Clinical Trial Data Mintz
Jan
18
2022
Supreme Court Halts Implementation of OSHA Vaccine-or-Test Rule (US) Squire Patton Boggs (US) LLP
Jan
18
2022
OSHA’s “Vax-or-Test” ETS: Where Do We Go From Here? (US) Squire Patton Boggs (US) LLP
Jan
18
2022
Not Positive: Last Week’s Lab Fraud Schemes Tycko & Zavareei LLP
Jan
18
2022
Tennessee Lawmakers to Consider Multiple Cannabis Proposals Bradley Arant Boult Cummings LLP
Jan
18
2022
Egg Regulatory Program Standards Announced Keller and Heckman LLP
Jan
15
2022
After the Supreme Court Decision, What Comes Next for OSHA and COVID-19 Beveridge & Diamond PC
Jan
15
2022
Minneapolis and St. Paul to Require Proof of Vaccination or Negative Test for Certain Businesses Jackson Lewis P.C.
Jan
15
2022
Building on the Success of Medicare-Medicaid Plans, CMS Proposes Modifications for D-SNPs Mintz
Jan
15
2022
Greenberg Traurig January 2022 Competition Currents: China and Japan Greenberg Traurig, LLP
Jan
14
2022
New York City Passes the Sweet Truth Act Keller and Heckman LLP
Jan
14
2022
Italian Ministers Announce Timetable for Investment in Digital Health Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins